MoonLake Immunotherapeutics - Class A

NAS:MLTX (Switzerland)   Class A
$ 38.74 +0.28 (+0.73%) 09:09 PM EST
At Loss
P/B:
4.49
Volume:
454.64K
Avg Vol (2M):
316.00K
Trade In:
Volume:
454.64K
At Loss
Avg Vol (2M):
316.00K

Business Description

MoonLake Immunotherapeutics
NAICS : 541720 SIC : 2833
ISIN : KY61559X1045

Share Class Description:

MLTX: Class A
Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. The company derives maximum revenue from United Kingdoms.
Name Current Vs Industry Vs History
Cash-To-Debt 149.43
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.89
9-Day RSI 32.87
14-Day RSI 37.56
6-1 Month Momentum % -32.09
12-1 Month Momentum % 57.84

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 62.12
Quick Ratio 62.12
Cash Ratio 61.39

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -20.92

Financials (Next Earnings Date:2024-08-09 Est.)

MLTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MLTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MoonLake Immunotherapeutics Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.73
Beta 0
Volatility % 103.78
14-Day RSI 37.56
14-Day ATR ($) 1.716926
20-Day SMA ($) 41.1455
12-1 Month Momentum % 57.84
52-Week Range ($) 35.11 - 64.98
Shares Outstanding (Mil) 62.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MoonLake Immunotherapeutics Filings

Filing Date Document Date Form
No Filing Data

MoonLake Immunotherapeutics Stock Events

Financials Calendars
Event Date Price($)
No Event Data

MoonLake Immunotherapeutics Frequently Asked Questions

What is MoonLake Immunotherapeutics(MLTX)'s stock price today?
The current price of MLTX is $38.74. The 52 week high of MLTX is $64.98 and 52 week low is $35.11.
When is next earnings date of MoonLake Immunotherapeutics(MLTX)?
The next earnings date of MoonLake Immunotherapeutics(MLTX) is 2024-08-09 Est..
Does MoonLake Immunotherapeutics(MLTX) pay dividends? If so, how much?
MoonLake Immunotherapeutics(MLTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1